Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code:
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - information on reported
This is in reference
to Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
regarding a news item published in "Sky News" and available at the link: https://news.sky.com/story/indian-pharma-group-dr-reddys-eyes-swoop-on-nicotinell-13049500
on January 16, 2024, with the heading "Indian pharma group Dr Reddy's eyes swoop on Nicotinell".
The said news item is about "Dr Reddy's Laboratories,
an Indian pharmaceutical group, is in talks to buy Nicotinell, the anti-smoking aid, from its FTSE-100 parent company". In this
regard, please note that the Company does not comment on market speculations and there is currently no such event or information which
requires a disclosure under Regulation 30 of the SEBI Listing Regulations.
In compliance with Regulation 30 of the SEBI Listing
Regulations, the Company makes prompt disclosures, as and when any event or information is considered material or warrants such disclosure
under the said Regulations.
This is for your information.
For Dr. Reddy's Laboratories Limited
| /s/ K Randhir Singh | |
| K Randhir Singh |
Company Secretary, Compliance Officer and Head-CSR